Search / Trial NCT06230679

Effectiveness of NESA in the Treatment of Cancer Survivors

Launched by ANÍBAL BÁEZ SUÁREZ · Jan 19, 2024

Trial Information

Current as of December 21, 2024

Recruiting

Keywords

Cancer Physical Therapy Modality Electric Stimulation Therapy

ClinConnect Summary

This clinical trial is studying the effectiveness of a device called NESA in helping cancer survivors who are dealing with ongoing symptoms like pain, fatigue, and sleep problems. These issues can significantly affect the quality of life for many people who have survived cancer. The trial is currently recruiting participants who are cancer survivors, specifically those who have been cancer-free for at least five years and experience one or more of these common symptoms.

To be eligible for the trial, participants must be between the ages of 65 and 74 or 29 and 219 years old. However, those currently battling cancer or who have certain medical conditions—like having a pacemaker or being pregnant—cannot participate. If someone joins the study, they can expect to use the NESA device as part of their treatment, which aims to improve their symptoms and overall well-being. This trial is an important step in understanding how to better support cancer survivors in their recovery journey.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Be a cancer survivor (5 years after discharge)
  • Have 1 of the 3 symptoms of the most common cluster: sleep problems, chronic fatigue, chronic neuro-muscular pain.
  • Exclusion Criteria:
  • Not have an active oncological process
  • Present any of the contraindications of the NESA-XSignal device: pacemaker, internal bleeding, skin in poor condition (ulcerations or wounds), acute febrile processes, acute thrombophlebitis, pregnancy, phobia of electricity.

Trial Officials

Gabriel Amengual Jaume, MSc

Principal Investigator

University of Las Palmas de Gran Canaria

About Aníbal Báez Suárez

Aníbal Báez Suárez is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative clinical studies. With a focus on ethical practices and regulatory compliance, the organization collaborates with healthcare professionals and institutions to design and execute trials that explore new therapeutic options across various medical fields. Driven by a passion for scientific excellence, Aníbal Báez Suárez emphasizes transparency and integrity in all research endeavors, aiming to contribute to the global body of knowledge and enhance the quality of healthcare.

Locations

Santa Maria Del Camí, Balearic, Spain

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0